Beyond Air™ Reports Financial Results for Fiscal First Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Beyond Air, Inc. (XAIR) Misses Q1 EPS by 39c
August 14, 2019 4:14 PM EDTBeyond Air, Inc. (NASDAQ: XAIR) reported Q1 EPS of ($0.67), $0.39 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $627.47 thousand versus the consensus estimate of $1.06 million.
Key Highlights
Remains on track to file a Premarket Approval (PMA) submission with the FDA for the treatment of persistent pulmonary hypertension of the newborn (PPHN) with our LungFit* PH system in the third quarter of calendar 2019. Anticipates obtaining CE Mark for LungFit* PH for the treatment of PPHN and for the treatment of pulmonary hypertension associated... More